Milestone Pharmaceuticals (NasdaqGS:MIST) Q3 2026 Earnings call November 13, 2026 08:30 AM ET Speaker0 Greetings, and welcome to the Milestone Pharmaceuticals third quarter earnings conference call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star 0 on your telephone keypad. As a reminder, this conference is being recorded. I would now like t ...

Launch of CARDAMYST® (etripamil) nasal spray marked by steady prescription growth, new prescriber expansion and improving commercial coverage Company is reducing operating expenses by approximately 30% while prioritizing sales force efforts for CARDAMYST; expects cash runway into late 2028 AFib-RVR Phase 3 trial on schedule with data expected in 2H 2028 MONTREAL and CHARLOTTE, N.C., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the quart ...